A potential risk factor of essential hypertension in case-control study: MicroRNAs miR-10a-5p

References

• Husain K, Ferder L, Ansari RA, Lalla J. Chronic ethanol ingestion induces aortic inflammation/oxidative endothelial injury and hypertension in rats. Hum Exp Toxicol. 2011;30(8):930–39. doi:10.1177/0960327110384520.
   PubMed Web of Science ®Google Scholar
• Suarez Y, Sessa WC. MicroRNAs as novel regulators of angiogenesis. Circ Res. 2009;104(4):442–54. doi:10.1161/circresaha.108.191270.
   PubMed Web of Science ®Google Scholar
• Bonner G. Use of behavioral therapies in hypertention. MMW Fortschr Med. 2015;157(9):63–64. doi:10.1007/s15006-015-3086-2.
   PubMedGoogle Scholar
• Iaitskii NA, Bedrov A, Maslevtsov DV, Tsvetkova EA, Moiseev AA. Ischemic heart disease and arterial hypertention as risk factors of surgical treatment of patients with infrarenal segment of aortic aneurysm. Vestn Khir Im I I Grek. 2013;172(1):11–15.
   Google Scholar
• Leopold JA. Catheter-based therapies for patients with medication-refractory pulmonary arterial hypertension. Circ Cardiovasc Interv. 2015;8(11):e003332. doi:10.1161/circinterventions.115.003332.
   PubMed Web of Science ®Google Scholar
• Whitworth JA. World health organization (WHO)/International society of hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21(11):1983–92. doi:10.1097/01.hjh.0000084751.37215.d2.
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102–14. doi:10.1038/nrg2290.
   PubMed Web of Science ®Google Scholar
• Kriegel AJ, Baker MA, Liu Y, Liu P, Cowley AW Jr., Liang M. Endogenous microRNAs in human microvascular endothelial cells regulate mRNAs encoded by hypertension-related genes. Hypertension. 2015;66(4):793–99. doi:10.1161/hypertensionaha.115.05645.
   PubMed Web of Science ®Google Scholar
• Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A. 2010;107(30):13450–55. doi:10.1073/pnas.1002120107.
   PubMed Web of Science ®Google Scholar
• Wu R, Tang S, Wang M, Xu X, Yao C, Wang S. MicroRNA-497 induces apoptosis and suppresses proliferation via the Bcl-2/Bax-caspase9-caspase3 pathway and cyclin D2 protein in HUVECs. PLoS One. 2016;11(12):e0167052. doi:10.1371/journal.pone.0167052.
   PubMed Web of Science ®Google Scholar
• Cordes KR, Srivastava D. MicroRNA regulation of cardiovascular development. Circ Res. 2009;104(6):724–32. doi:10.1161/circresaha.108.192872.
   PubMed Web of Science ®Google Scholar
• Latronico MV, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol. 2009;6(6):419–29. doi:10.1038/nrcardio.2009.56.
   PubMed Web of Science ®Google Scholar
• Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460(7256):705–10. doi:10.1038/nature08195.
   PubMed Web of Science ®Google Scholar
• Portnoy V, Huang V, Place RF, Li LC. Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA. 2011;2(5):748–60. doi:10.1002/wrna.90.
   PubMed Web of Science ®Google Scholar
• Latronico MV, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res. 2007;101(12):1225–36. doi:10.1161/circresaha.107.163147.
   PubMed Web of Science ®Google Scholar
• Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, Dart AM. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015;13(1):314. doi:10.1186/s12967-015-0672-0.
   PubMedGoogle Scholar
• Luo L, Chen B, Li S, Wei X, Liu T, Huang Y, Lin X. Plasma miR-10a: a potential biomarker for coronary artery disease. Dis Markers. 2016;2016:1–5. doi:10.1155/2016/3841927.
   Google Scholar
• Kumar S, Kim CW, Simmons RD, Jo H. Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs. Arterioscler Thromb Vasc Biol. 2014;34(10):2206–16. doi:10.1161/atvbaha.114.303425.
   PubMed Web of Science ®Google Scholar
• Meyer S, van der Meer P, van Tintelen JP, van Den Berg MP. Sex differences in cardiomyopathies. Eur J Heart Fail. 2014;16(3):238–47. doi:10.1002/ejhf.15.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov. 2006;5(5):425–38. doi:10.1038/nrd2032.
   PubMed Web of Science ®Google Scholar
• Evangelista AM, Deschamps AM, Liu D, Raghavachari N, Murphy E. miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1. Physiol Genomics. 2013;45(12):493–98. doi:10.1152/physiolgenomics.00008.2013.
   PubMed Web of Science ®Google Scholar
• Queiros AM, Eschen C, Fliegner D, Kararigas G, Dworatzek E, Westphal C, Sanchez Ruderisch H, Regitz-Zagrosek V. Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. Int J Cardiol. 2013;169(5):331–38. doi:10.1016/j.ijcard.2013.09.002.
   PubMed Web of Science ®Google Scholar
• Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National registry of myocardial infarction 2 participants. N Engl J Med. 1999;341(4):217–25. doi:10.1056/nejm199907223410401.
   PubMed Web of Science ®Google Scholar
• Antoniucci D, Valenti R, Moschi G, Migliorini A, Trapani M, Santoro GM, Bolognese L, Dovellini EV. Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol. 2001;87(3):289–93. doi:10.1016/S0002-9149(00)01360-6.
   PubMed Web of Science ®Google Scholar
• Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992;86(4):1099–107. doi:10.1161/01.CIR.86.4.1336.
   PubMedGoogle Scholar
• Liao Y, Cooper RS, Mensah GA, McGee DL. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation. 1995;92(4):805–10. doi:10.1161/01.CIR.92.4.805.
   PubMed Web of Science ®Google Scholar
• Magnani JW, Danik HJ, Dec GW Jr., DiSalvo TG. Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am Heart J. 2006;151(2):463–70. doi:10.1016/j.ahj.2005.03.037.
   PubMed Web of Science ®Google Scholar
• Woodruff JF. Viral myocarditis. A review. Am J Pathol. 1980;101(2):425–84. doi:10.1016/j.ajpath.2012.02.002.
   PubMed Web of Science ®Google Scholar
• Fanelli C, Delle H, Cavaglieri RC, Dominguez WV, Noronha IL. Gender differences in the progression of experimental chronic kidney disease induced by chronic nitric oxide inhibition. Biomed Res Int. 2017;2017(2):2159739. doi:10.1155/2017/2159739.
   PubMedGoogle Scholar
• Donishi T, Terada M, Kaneoke Y. Effects of gender, digit ratio, and menstrual cycle on intrinsic brain functional connectivity: a whole-brain, voxel-wise exploratory study using simultaneous local and global functional connectivity mapping. Brain Behav. 2018;8(1):e00890. doi:10.1002/brb3.890.
   PubMed Web of Science ®Google Scholar
• Chung N, Park HY, Park MY, Hwang YY, Lee CH, Han JS, So J, Kim J, Park J, Lim K. Association of daily physical activity level with health-related factors by gender and age-specific differences among Korean adults based on the sixth (2014-2015) Korea national health and nutrition examination survey. J Exerc Nutrition Biochem. 2017;21(2):30–38. doi:10.20463/jenb.2017.0026.
   PubMedGoogle Scholar
• Sesso HD, Cook NR, Buring JE, Manson JE, Gaziano JM. Alcohol consumption and the risk of hypertension in women and men. Hypertension. 2008;51(4):1080–87. doi:10.1161/hypertensionaha.107.104968.
   PubMed Web of Science ®Google Scholar
• Kaplan NM. Alcohol and hypertension. Lancet. 1995;345(8965):1588–89. doi:10.1111/j.1440-1681.1995.tb01977.x.
   PubMed Web of Science ®Google Scholar
• Huang J, Wu J, Li Y, Li X, Yang T, Yang Q, Jiang Y. Deregulation of serum microRNA expression is associated with cigarette smoking and lung cancer. Biomed Res Int. 2014;2014:364316. doi:10.1155/2014/364316.
   PubMedGoogle Scholar
• Krishnan AR, Zheng H, Kwok JG, Qu Y, Zou AE, Korrapati A, Li PX, Califano JA, Hovell MF, Wang-Rodriguez J, et al. A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma. Oral Oncol. 2017;72:56–64.
   PubMed Web of Science ®Google Scholar
• Xu M, Li J, Chen X, Han L, Li L, Liu Y. MTHFD1 promoter hypermethylation increases the risk of hypertension. Clin Exp Hypertens. 2018;2018(5):1–6. doi:10.1080/10641963.2018.1501057.
   Google Scholar
• Hamoda G, Tayel S, Elshayeb E. Association of genetic variants of pentraxin 3 rs3816527 with hypertension in Chronic kidney disease patients. Mol Cell Biochem. 2017;425(1–2):1–10. doi:10.1007/s11010-016-2874-z.
   PubMed Web of Science ®Google Scholar
• Trevisani F, Ghidini M, Larcher A, Lampis A, Lote H, Manunta P, Alibrandi MTS, Zagato L, Citterio L, Dell’Antonio G, et al. MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma. Br J Cancer. 2016;115(11):1–8. doi:10.1038/bjc.2016.329.
   PubMed Web of Science ®Google Scholar
• Wu D, Talbot CC Jr., Liu Q, Jing Z, Damico RL, Tuder R, Barnes KC, Hassoun PM, Gao L. Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension. J Mol Med (Berl). 2016;94(8):875–85. doi:10.1007/s00109-016-1426-z.
   PubMed Web of Science ®Google Scholar